Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$BMRN Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.23 up 91.67% YoY • Reported revenue of $1.02B up 32.02% YoY • BioMarin updated FY2026 guidance to total revenues of $3.8B, Metabolic Conditions $2.68B, VOXZOGO $975M, and Non-GAAP Diluted EPS $2.80 to $3.10.
1

Price since post

Full Details

Advertisement|Remove ads.